Back to today’s briefing

Story perspectives

Revolutionary Test Boosts Alzheimer's Diagnosis and Treatment

6/9/2025

44 5

Summary

Story summary

A groundbreaking study from Ningbo, China, reveals that combining Surface-Enhanced Raman Spectroscopy (SERS) with Enzyme-Linked Immunosorbent Assay (ELISA) dramatically enhances the diagnostic accuracy for Alzheimer's disease, mild cognitive impairment, and late-life depression. This innovative approach opens doors to personalized treatment strategies, offering hope for those battling neurodegenerative and neuropsychiatric disorders.

1 of 1

Story summary

A groundbreaking study from Ningbo, China, reveals that combining Surface-Enhanced Raman Spectroscopy (SERS) with Enzyme-Linked Immunosorbent Assay (ELISA) dramatically enhances the diagnostic accuracy for Alzheimer's disease, mild cognitive impairment, and late-life depression. This innovative approach opens doors to personalized treatment strategies, offering hope for those battling neurodegenerative and neuropsychiatric disorders.